Medriva: Your Healthcare Partner
WEBNavigating the Maze of Food Intolerances: Insights and Advice for Better Health. By Medriva Correspondents. May 02, 2024 11:11 EST 2 Min read. Medriva Where AI and Medicine Converge. Experience personalized health insights with our AI doctor. Trustworthy content curated by experts. Join us to shape the future of digital healthcare.
About Us - Medriva
WEBAt Medriva, our mission is to deliver accurate and up-to-date medical news to empower individuals with knowledge about their health and well-being. We strive to provide a trusted source of medical information that is accessible to everyone. In an age awash with information, our commitment stands firm—to provide reliable and impactful health ...
FDA Approves Amtagvi (Lifileucel), a Revolutionary TIL Therapy for ...
WEBFeb 17, 2024 · Clinical Trial Success. The approval of lifileucel was supported by promising data from the phase 2 C-144-01 clinical trial. The trial demonstrated an objective response rate (ORR) of 31.5%, indicating that nearly a third of …
FDA Approves Revolutionary Cell Therapy for Solid Tumors: A ...
WEBFeb 17, 2024 · The FDA has approved Amtagvi, the first cell therapy for solid tumors, marking a major milestone in cancer treatment. Learn about the promise, challenges, and prospects of this groundbreaking treatment.
Innovative Clinical Trials That Will Transform Medicine in 2024
WEBDec 15, 2023 · Perhaps one of the most anticipated advancements in 2024 is the potential development of a vaccine against HIV. The HIV Vaccine Trials Network is conducting a clinical trial for the HIV vaccine at multiple sites. This vaccine could have an enormous impact on global public health, potentially preventing millions of new HIV infections.
New Therapies and Treatments Awaiting FDA Approval in 2024: A …
WEBFeb 14, 2024 · Amylyx's Relyvrio is also anticipated to be a blockbuster drug. Further, the FDA is expected to make several important decisions in the first quarter of 2024, including new drugs for Alzheimer's, liver disease, and cancer cell therapy. Lilly's market valuation has surged due to the success of tirzepatide in treating obesity and diabetes.
The OCA Peptide: A Revolutionary Discovery and New Therapeutic …
WEBFeb 20, 2024 · The discovery of the OCA peptide and its role in activating key immune proteins is a game-changer. This revelation holds great potential for the development of innovative immunotherapies for a range of diseases, from autoimmune disorders to cancer and non-communicable diseases linked to obesity. As research in this area continues, …
Groundbreaking Study Reveals 275 Million New Genetic Variants: …
WEBFeb 20, 2024 · Groundbreaking study funded by the NIH reveals 1 billion genetic variants and highlights the impact of genetic diversity on disease risk. Learn more about the implications for drug development and health equity.
Medical Breakthroughs
WEBMar 7, 2024 · A Breakthrough in Alzheimer's Diagnosis: The Promise and Challenges of the p-Tau 217 Blood Test. By Anthony Raphael. Mar 07, 2024 06:50 EST. Medical Breakthroughs.
Proposed 2025 Updates for Medicare Advantage and Medicare …
WEBJan 31, 2024 · The proposed payment updates for Medicare Advantage and Medicare Part D programs for CY2025 aim to increase payments to Medicare Advantage plans by 2.75% and to Medicare Part D plans by 1.25%. These proposed changes also include adjustments to risk adjustment and quality measures which will impact beneficiaries, providers, and …
Skip to content